Background: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and
effective for sudden cardiac death prevention. However, patients in previous S-ICD studies …

Background Subcutaneous implantable cardioverter‐defibrillators (S‐ICDs) have been of
great interest as an alternative to transvenous implantable cardioverter‐defibrillators (TV …

Sudden cardiac arrest (SCA) in young athletes is rare, with an estimated incidence ranging
from 0.1 to 2 per 100,000 per athlete year. The creation of SCA registries can help provide …

Background: Implantable cardioverter defibrillators (ICDs) improve survival in patients at risk
for cardiac arrest, but are associated with intravascular lead-related complications. The …

Introduction Comparison data on management of device‐related complications and their
impact on patient outcome and healthcare utilization between subcutaneous implantable …

Background Despite expanding indication of the subcutaneous implantable cardioverter
defibrillator (S-ICD) in clinical practice, limited data exists on safety and efficacy of S-ICD in …

Abstract Aims Patient-reported outcomes (PROs) provide important insights into patients'
acceptance of their medical devices. Avoid Transvenous Leads in Appropriate Subjects …

Background One third of primary prevention implantable cardioverter‐defibrillator patients
receive appropriate therapy, but all remain at risk of defibrillator complications. Information …

Fontan surgery and its modifications have improved survival in various forms of
univentricular hearts. A regular atrial rhythm with atrioventricular synchrony is one of the …

Introduction The subcutaneous implantable cardioverter defibrillator (S‐ICD) is an
alternative to a transvenous ICD in patients who meet the criteria for ICD implantation …